Biodesix shareholders approve reverse stock split ratio range 1:2 to 1:20

BIODESIX INC

Shareholders approved reverse stock split of common stock at ratio between 1-for-2 and 1-for-20, as determined by board.
KPMG LLP ratified as independent auditor for FY 2025 with 124.9M votes for.
ESPP amended: shares available increased by 1.45M; annual automatic increase cap raised to 3.0M.
Lawrence T. Kennedy Jr. and Matthew Strobeck elected as Class II directors at annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.